Log in

OTCMKTS:MBGNF - Med Biogene Stock Price, Forecast & News

$0.02
0.00 (0.00 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.02
MA: $0.03
$0.03
52-Week Range
$0.02
Now: $0.02
$0.03
VolumeN/A
Average Volume4,980 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:MBGNF
CUSIPN/A
CIKN/A
Phone604-732-8821

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MBGNF News and Ratings via Email

Sign-up to receive the latest news and ratings for MBGNF and its competitors with MarketBeat's FREE daily newsletter.


Med Biogene (OTCMKTS:MBGNF) Frequently Asked Questions

What is Med Biogene's stock symbol?

Med Biogene trades on the OTCMKTS under the ticker symbol "MBGNF."

How were Med Biogene's earnings last quarter?

Med Biogene Inc (OTCMKTS:MBGNF) posted its earnings results on Friday, November, 29th. The company reported ($0.01) EPS for the quarter. View Med Biogene's Earnings History.

Has Med Biogene been receiving favorable news coverage?

Headlines about MBGNF stock have been trending extremely negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Med Biogene earned a news impact score of -5.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Med Biogene.

Who are Med Biogene's key executives?

Med Biogene's management team includes the folowing people:
  • Dr. Iain Weir-Jones Ph.D., P.Eng., FGS, Chairman & CEO
  • Mr. Ibrahim Ghobrial, Chief Financial Officer

How do I buy shares of Med Biogene?

Shares of MBGNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Med Biogene's stock price today?

One share of MBGNF stock can currently be purchased for approximately $0.02.

What is Med Biogene's official website?

The official website for Med Biogene is http://www.medbiogene.com/.

How can I contact Med Biogene?

The company can be reached via phone at 604-732-8821.


MarketBeat Community Rating for Med Biogene (OTCMKTS MBGNF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  51
MarketBeat's community ratings are surveys of what our community members think about Med Biogene and other stocks. Vote "Outperform" if you believe MBGNF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBGNF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel